Samian Sulaiman, MD
Cardiovascular Disease · Huntington, WVNPI 1972851335
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (47.2%), travel and lodging and education — rather than concentrated in one kind of arrangement. 17 manufacturers reported payments, led by Medtronic at 30.0% of the total.
Across 100 payments — averaging $71.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$2K
- W. L. Gore & Associates, Inc.$2K
- Abbott$1K
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$757
- Boston Scientific$241
- Edwards Lifesciences$211
- plus $852 from 11 others
Across 1 payment — averaging $91.86 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Abiomed$92
What the payments were for
- Travel & lodging$3,24445%
- Food & beverage$3,37047%
- Education$5227%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 23 | $2,139 |
| W. L. Gore & Associates, Inc. | 8 | $1,508 |
| Abbott | 16 | $1,428 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 35 | $757 |
| Boston Scientific | 2 | $241 |
| Edwards Lifesciences | 2 | $211 |
| Inari Medical, Inc. | 1 | $134 |
| Heartflow, Inc. | 1 | $126 |
| Cordis US CORP. | 1 | $102 |
| Shockwave Medical, Inc | 1 | $97 |
| Cathworks, Inc. | 1 | $84 |
| Teleflex LLC | 2 | $76 |
| Stryker | 2 | $74 |
| Penumbra, Inc. | 1 | $63 |
| Kestra Medical Technology Services, Inc. | 2 | $56 |
| AstraZeneca | 1 | $20 |
| Pfizer | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- COREVALVE EVOLUT R$1,453
- TRICLIP$803
- GORE CARDIOFORM Septal Occluder$722
- GORE CARDIOFORM ASD Occluder$669
- WATCHMAN FLX$141
- EnSite Precision Cardiac Mapping System$136
- FLOWTRIEVER CATHETER, S$134
- CT THROMBECTOMY SYSTEM KIT$134
- ENSITE$133
- FFRct$126
- LifeVest$116
- HeartWare HVAD$114
- CARDIOMEMS$110
- Edwards SAPIEN 3 Transcatheter Heart Valve$105
- SAPIEN 3 Ultra RESILIA$105
- MYNX CONTROL$102
How this compares
$7,135 in reported general payments places this provider in the 75th percentile of 100 cardiovascular disease providers in West Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BrilintaTicagrelor | 13 | $8,234 |
| ClopidogrelClopidogrel Bisulfate | 138 | $1,211 |
| Pantoprazole Sodium | 23 | $160 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 12 | $125 |
| Furosemide | 13 | $66 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaBrilinta | $20 | $8,23413 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 100 cardiovascular disease providers in West Virginia.
Other cardiovascular disease in Huntington
- Kofi OseiHuntington$87K
- Esam BaryunHuntington$55K
- Rameez SayyedHuntington$21K
- Jason MaderHuntington$13K
- Mark StudenyHuntington$7K
- Ellen ThompsonHuntington$6K
- Amrit ThakurHuntington$5K
- Mehiar El-HamdaniHuntington$4K
- George LinsenmeyerHuntington$2K
- Sarah RinehartCharleston$303K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.